SCHEMBL2105230

SCHEMBL2105230

Cc1[c]c(C)c(-c2cccc([N+](=O)[O-])c2)c(C(F)(C(F)(F)F)C(F)(F)C(F)(F)F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 3/20 0.38
NPC1 O15118 3/20 0.38
TSHR P16473 2/20 0.38
POLB P06746 1/20 0.38
ACHE P22303 1/20 0.38
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
MMP13 P45452 1/20 0.36
AKR1C3 P42330 3/20 0.36
AKR1C2 P52895 3/20 0.36
PTGS2 P35354 1/20 0.36
LMNA P02545 1/20 0.36
JAK2 O60674 1/20 0.35
TYK2 P29597 1/20 0.35
MGAM O43451 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2106579 0.87 ALDH1A1 (0.36) MEN1KMT2AALDH1A1TSHRACHE
SCHEMBL1948387 0.81 ALDH1A1 (0.38) MEN1KMT2AALDH1A1TSHRACHE
SCHEMBL2106490 0.81 TGFBR1 (0.32) ACHEMGAMGAASIMGAM2
SCHEMBL2106611 0.80 MAPT (0.37) MEN1KMT2AALDH1A1NPC1TSHR
SCHEMBL2106091 0.78 ALDH1A1 (0.35) MEN1KMT2AALDH1A1NPC1LMNA
SCHEMBL1950940 0.77 FNTA (0.37)
SCHEMBL17554983 0.76 ALDH1A1 (0.34) MEN1KMT2AALDH1A1TSHRACHE
SCHEMBL2103791 0.75 AR (0.31)
SCHEMBL2105845 0.74
SCHEMBL2104340 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163804-B2 Composition for preventing harmful organisms MITSUI CHEMICALS, INC. (JP) 2012-04-24 US disclosed
US-20090162453-A1 COMPOSITION FOR PREVENTING HARMFUL ORGANISMS MITSUI CHEMICALS, INC (JP) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090162453-A1 COMPOSITION FOR PREVENTING HARMFUL ORGANISMS PRDX3, CYP1A1, GSTA1 MEN1 485/4885KMT2A 1594/4885ALDH1A1 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.